Platelet Count Decreased
156 drugs90,842 FAERS reportsMedDRA PT
GET
/api/v1/reaction/platelet-count-decreasedReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
Drugs reporting Platelet Count Decreased (156)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Pregnenolone1100%
- 2Dyclonine4340%
- 3Rilzabrutinib5226%
- 4Manganese Sulfate2025%
- 5Epstein-barr Virus125%
- 6Givinostat11023%
- 7Caffeic Acid1122%
- 8Niraparib4,11319%
- 9Eltrombopag3,97018%
- 10Imetelstat2616%
- 11Revumenib10916%
- 12Avatrombopag36716%
- 13Fostamatinib84613%
- 14Cedazuridine9112%
- 15Romiplostim1,70612%
- 16Pacritinib2799.8%
- 17Tisagenlecleucel4139.3%
- 18Pralatrexate578.9%
- 19Belinostat298.5%
- 20Betibeglogene Autotemcel48.3%
- 21Selinexor6637.9%
- 22Xenon17.7%
- 23Caplacizumab1257.6%
- 24Onasemnogene Abeparvovec1677.5%
- 25Trilaciclib177.3%
- 26Gilteritinib2747.2%
- 27Danazol1937.0%
- 28Quizartinib386.8%
- 29Manganese256.6%
- 30Gemtuzumab Ozogamicin2356.5%
- 31Rucaparib5396.2%
- 32Ibritumomab Tiuxetan845.5%
- 33Zanubrutinib2085.4%
- 34Procarbazine2395.3%
- 35Ziftomenib15.3%
- 36Dinutuximab425.2%
- 37Phentolamine85.2%
- 38Vorinostat1065.0%
- 39Decitabine2424.9%
- 40Peginterferon Alfa-2a2,5784.8%
- 41Glutathione974.6%
- 42Venetoclax2,7234.6%
- 43Polatuzumab Vedotin4144.5%
- 44Lomustine1114.4%
- 45Idarubicin484.4%
- 46Romidepsin734.4%
- 47Momelotinib514.3%
- 48Talazoparib734.3%
- 49Topotecan2914.3%
- 50Inavolisib174.3%
- 51Azacitidine1,2094.2%
- 52Inotuzumab Ozogamicin1204.2%
- 53Ribavirin2,5654.0%
- 54Dotatate2283.9%
- 55Iptacopan263.9%
- 56Dexrazoxane353.9%
- 57Avapritinib4433.9%
- 58Diflunisal313.9%
- 59Ruxolitinib2,6683.9%
- 60Fedratinib493.8%
- 61Enasidenib1223.8%
- 62Alemtuzumab7083.7%
- 63Ropeginterferon Alfa-2b623.7%
- 64Nelarabine353.7%
- 65Ixabepilone383.6%
- 66Pentamidine443.6%
- 67Ivosidenib693.6%
- 68Trabectedin813.6%
- 69Linezolid1,0313.6%
- 70Epcoritamab413.5%
- 71Ixazomib9943.5%
- 72Auranofin73.4%
- 73Eculizumab1,8203.4%
- 74Sunitinib1,3313.4%
- 75Quazepam103.3%
- 76Hydroxyurea6903.3%
- 77Tazemetostat523.3%
- 78Emapalumab63.3%
- 79Malate1,3313.2%
- 80Granisetron3873.2%
- 81Ponatinib1663.2%
- 82Thioguanine673.2%
- 83Pralsetinib543.2%
- 84Lisocabtagene Maraleucel253.1%
- 85Deferasirox8193.1%
- 86Palonosetron1933.1%
- 87Dexchlorpheniramine313.1%
- 88Danicopan73.0%
- 89Lenvatinib9543.0%
- 90Pirtobrutinib213.0%
- 91Temozolomide6183.0%
- 92Sodium Phosphate5212.9%
- 93Tigecycline1722.9%
- 94Zolbetuximab312.9%
- 95Sotatercept1122.9%
- 96Nilotinib8232.8%
- 97Crotamiton172.8%
- 98Rolapitant152.8%
- 99Filgrastim1,1522.8%
- 100Cytarabine1,6782.8%
- 101Anagrelide622.8%
- 102Mesna2272.7%
- 103Daunorubicin1002.7%
- 104Acyclovir3,0732.7%
- 105Radium1892.7%
- 106Miglitol252.7%
- 107Bendamustine7162.7%
- 108Argatroban392.6%
- 109Elotuzumab1342.6%
- 110Asciminib762.6%
- 111Obinutuzumab4102.6%
- 112Entecavir2942.6%
- 113Prochlorperazine9572.6%
- 114Loncastuximab Tesirine92.6%
- 115Tranexamic Acid2192.5%
- 116Naldemedine402.5%
- 117Epinastine272.4%
- 118Palbociclib2,2872.4%
- 119Lurbinectedin252.4%
- 120Epirubicin1472.4%
- 121Cilastatin982.4%
- 122Imipenem982.4%
- 123Isatuximab1222.3%
- 124Gemcitabine1,1932.3%
- 125Sulbactam592.3%
- 126Lenalidomide9,5032.3%
- 127Vincristine6452.3%
- 128Cisplatin1,7152.3%
- 129Tipiracil2302.2%
- 130Tremelimumab862.2%
- 131Valproate4372.2%
- 132Carfilzomib5952.1%
- 133Trifluridine2322.1%
- 134Lutetium3762.1%
- 135Caspofungin972.1%
- 136Daratumumab8512.1%
- 137Ibrutinib1,6362.1%
- 138Dexamethasone6,2132.0%
- 139Itraconazole2342.0%
- 140Glofitamab412.0%
- 141Pemetrexed7342.0%
- 142Atezolizumab7382.0%
- 143Etoposide1,4392.0%
- 144Olaparib3891.9%
- 145Glasdegib91.9%
- 146Bivalirudin181.9%
- 147Ramucirumab1151.9%
- 148Bevacizumab2,3741.9%
- 149Isavuconazonium641.9%
- 150Posaconazole2881.8%
- 151Cyclophosphamide3,0951.8%
- 152Durvalumab3351.8%
- 153Pomalidomide1,7311.7%
- 154Levoleucovorin601.7%
- 155Tetraxetan1481.2%
- 156Vipivotide Tetraxetan1481.2%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- White Blood Cell Count Decreased59 shared · 0.32
- Thrombocytopenia93 shared · 0.31
- Neutropenia80 shared · 0.27
- Febrile Neutropenia66 shared · 0.27
- Anaemia115 shared · 0.23
- Disease Progression71 shared · 0.22
- Haemoglobin Decreased41 shared · 0.20
- Neutrophil Count Decreased32 shared · 0.19
- Sepsis56 shared · 0.18
- Malignant Neoplasm Progression42 shared · 0.16
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.